Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.

[1]  J. Bishop,et al.  Low-grade non-intestinal-type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity , 2022, Modern Pathology.

[2]  Yaqian Qu,et al.  The Role of cAMP-PKA Pathway in Lactate-Induced Intramuscular Triglyceride Accumulation and Mitochondria Content Increase in Mice , 2021, Frontiers in Physiology.

[3]  M. Sobrinho-Simões,et al.  Inherited Thyroid Tumors With Oncocytic Change , 2021, Frontiers in Endocrinology.

[4]  Tsuyoshi Saito,et al.  Upregulation of follistatin and low apoptotic activity in intraductal oncocytic papillary neoplasm of the pancreatobiliary system , 2020, Scientific Reports.

[5]  L. Wood,et al.  Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct. , 2020, Gastroenterology.

[6]  O. Basturk,et al.  DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma , 2019, Modern Pathology.

[7]  D. Samuels,et al.  Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background. , 2019, Mitochondrion.

[8]  Y. Nakanuma,et al.  Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes , 2017, Virchows Archiv.

[9]  S. Kawasaki,et al.  Fundic gland differentiation of oncocytic/pancreatobiliary subtypes of pancreatic intraductal papillary mucinous neoplasm , 2016, Histopathology.

[10]  Ju-Han Lee,et al.  KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis , 2016, SpringerPlus.

[11]  V. Jobanputra,et al.  The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes , 2016, Modern Pathology.

[12]  Yasunori Sato,et al.  Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm. , 2016, Human pathology.

[13]  Prashant Mishra,et al.  Metabolic regulation of mitochondrial dynamics , 2016, The Journal of cell biology.

[14]  Jin-Young Jang,et al.  A combination of molecular markers and clinical features improve the classification of pancreatic cysts. , 2015, Gastroenterology.

[15]  S. Simon,et al.  Transcriptomic characterization of fibrolamellar hepatocellular carcinoma , 2015, Proceedings of the National Academy of Sciences.

[16]  Hiromi Nakamura,et al.  Genomic spectra of biliary tract cancer , 2015, Nature Genetics.

[17]  F. Hazard,et al.  Genomic analysis of fibrolamellar hepatocellular carcinoma. , 2015, Human molecular genetics.

[18]  V. Vacic,et al.  Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma , 2014, Science.

[19]  L. Levin,et al.  cAMP and mitochondria. , 2013, Physiology.

[20]  Masakazu Yamamoto,et al.  Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms , 2011, The Journal of pathology.

[21]  R. Hruban,et al.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study , 2005, Virchows Archiv.

[22]  Dillwyn Williams,et al.  Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid , 2005, British Journal of Cancer.

[23]  M. Mansukhani,et al.  Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. , 2004, Cancer genetics and cytogenetics.

[24]  S. Yonezawa,et al.  The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. , 2002, Journal of hepato-biliary-pancreatic surgery.